Magazine Article | August 2, 2018

Mitigating Risks In Countries With Poor IP Protection

Source: Life Science Leader

By Gail Dutton, Contributing Writer
Follow Me On Twitter @GailLdutton

Global pharmaceutical companies set their sights on China when the concept of intellectual property (IP) was new and poorly understood. Now they are sizing up Latin America and Southeast Asia, where intellectual theft remains common. Although companies are reluctant to discuss their strategies for entering countries with weak IP protection, a new study of 142 pharmas in 118 countries reveals a key commonality in terms of protecting IP while opening new markets for commercialization, manufacturing, and R&D.

The strategy comes down to not putting all their eggs in one basket. Instead, companies are taking a regional approach to entry.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: